BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin X. Etiology of inflammatory bowel disease: A unified hypothesis. World J Gastroenterol 2012; 18(15): 1708-1722 [PMID: 22553395 DOI: 10.3748/wjg.v18.i15.1708] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen SJ, Liu XW, Liu JP, Yang XY, Lu FG. Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World J Gastroenterol 2014; 20(28): 9468-9475 [PMID: 25071341 DOI: 10.3748/wjg.v20.i28.9468] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
2 Qin X. High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria. Inflamm Bowel Dis 2021:izab142. [PMID: 34125213 DOI: 10.1093/ibd/izab142] [Reference Citation Analysis]
3 Laffin M, Fedorak R, Zalasky A, Park H, Gill A, Agrawal A, Keshteli A, Hotte N, Madsen KL. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Sci Rep. 2019;9:12294. [PMID: 31444382 DOI: 10.1038/s41598-019-48749-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
4 Pabari RM, Mattu C, Partheeban S, Almarhoon A, Boffito M, Ciardelli G, Ramtoola Z. Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model. Int J Pharm 2019;565:533-42. [PMID: 31085256 DOI: 10.1016/j.ijpharm.2019.05.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
5 Qin X. More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:e43-4. [PMID: 33331632 DOI: 10.1093/ibd/izaa329] [Reference Citation Analysis]
6 Aheman A, Gao F, Kuerbanjiang A, Li YX, Abuduhadeer M. Difference in DRB1* gene polymorphisms between Han and Uyghur ulcerative colitis patients in China. World J Gastroenterol 2013; 19(17): 2709-2713 [PMID: 23674880 DOI: 10.3748/wjg.v19.i17.2709] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
7 Bin Masud S, Jenkins C, Hussey E, Elkin-Frankston S, Mach P, Dhummakupt E, Aeron S. Utilizing machine learning with knockoff filtering to extract significant metabolites in Crohn's disease with a publicly available untargeted metabolomics dataset. PLoS One 2021;16:e0255240. [PMID: 34324558 DOI: 10.1371/journal.pone.0255240] [Reference Citation Analysis]
8 Chen LL, Zou YY, Lu FG, Li FJ, Lian GH. Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. World J Gastroenterol 2013; 19(32): 5347-5356 [PMID: 23983440 DOI: 10.3748/wjg.v19.i32.5347] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
9 Basson AR, Rodriguez-Palacios A, Cominelli F. Artificial Sweeteners: History and New Concepts on Inflammation. Front Nutr 2021;8:746247. [PMID: 34631773 DOI: 10.3389/fnut.2021.746247] [Reference Citation Analysis]
10 Qin X. How NOD2 and autophagy may be related to Crohn's disease? A view shifted from live microbes to luminal bacterial debris. Journal of Crohn's and Colitis 2014;8:88. [DOI: 10.1016/j.crohns.2013.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Qin X. Impaired inactivation of digestive proteases: The possible key factor for the high susceptibility of germ-free and antibiotic-treated animals to gut epithelial injury. World J Gastrointest Pathophysiol 2017; 8(1): 1-2 [PMID: 28251033 DOI: 10.4291/wjgp.v8.i1.1] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr 2016;21:184-98. [PMID: 26307347 DOI: 10.1017/S1092852915000449] [Cited by in Crossref: 89] [Cited by in F6Publishing: 40] [Article Influence: 14.8] [Reference Citation Analysis]
13 Myles IA. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J 2014;13:61. [PMID: 24939238 DOI: 10.1186/1475-2891-13-61] [Cited by in Crossref: 151] [Cited by in F6Publishing: 117] [Article Influence: 21.6] [Reference Citation Analysis]
14 Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, Lam M, Croniger CM, McLean MH, Durum SK, Pizarro TT, Ghannoum MA, Ilic S, McDonald C, Cominelli F. The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis. Inflamm Bowel Dis 2018;24:1005-20. [PMID: 29554272 DOI: 10.1093/ibd/izy060] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 39.5] [Reference Citation Analysis]
15 Rondanelli M, Lamburghini S, Faliva MA, Peroni G, Riva A, Allegrini P, Spadaccini D, Gasparri C, Iannello G, Infantino V, Alalwan TA, Perna S, Miccono A. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinol Diabetes Nutr (Engl Ed) 2021;68:17-46. [PMID: 32499202 DOI: 10.1016/j.endinu.2020.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kurada S, Alkhouri N, Fiocchi C, Dweik R, Rieder F. Review article: breath analysis in inflammatory bowel diseases. Aliment Pharmacol Ther 2015;41:329-41. [PMID: 25523187 DOI: 10.1111/apt.13050] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
17 Miner-williams WM, Moughan PJ. Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel. Nutr Res Rev 2016;29:40-59. [DOI: 10.1017/s0954422416000019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 6.4] [Reference Citation Analysis]
18 Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, Im E, Jung Y, Yoo J. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res 2020;43:153-69. [DOI: 10.1007/s12272-020-01219-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 27.0] [Reference Citation Analysis]
19 Qin X. The Possible Link Between Artificial Sweeteners Such as Saccharin and Sucralose and Inflammatory Bowel Disease Deserves Further Study: . Inflammatory Bowel Diseases 2016;22:E17. [DOI: 10.1097/mib.0000000000000760] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Keen OS, Linden KG. Re-Engineering an Artificial Sweetener: Transforming Sucralose Residuals in Water via Advanced Oxidation. Environ Sci Technol 2013;47:6799-805. [DOI: 10.1021/es304339u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
21 García-Domenech R, Gálvez-Llompart M, Zanni R, Recio MC, Gálvez J. QSAR methods for the discovery of new inflammatory bowel disease drugs. Expert Opin Drug Discov 2013;8:933-49. [PMID: 23668227 DOI: 10.1517/17460441.2013.800043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
22 Sünderhauf A, Pagel R, Künstner A, Wagner AE, Rupp J, Ibrahim SM, Derer S, Sina C. Saccharin Supplementation Inhibits Bacterial Growth and Reduces Experimental Colitis in Mice. Nutrients 2020;12:E1122. [PMID: 32316544 DOI: 10.3390/nu12041122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Wu H, Wei J, Wang K, Qi Y, Wang F. Mucus protectors: Promising therapeutic strategies for inflammatory bowel disease. Medical Hypotheses 2018;120:55-9. [DOI: 10.1016/j.mehy.2018.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Stojanović M, Šćepanović L, Todorović D, Mitrović D, Šćepanović V, Šćepanović R, Ilić S, Šćepanović T, Borović ML, Milićević Ž, Dragutinović V, Borozan S, Lalić I, Despotović S, Djuric D. Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-l-cysteine. Mol Cell Biochem 2018;440:53-64. [DOI: 10.1007/s11010-017-3155-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Qin X. May bacterial or pancreatic proteases play a critical role in inflammatory bowel disease? World J Gastroenterol 2014; 20(35): 12709-12710 [PMID: 25253982 DOI: 10.3748/wjg.v20.i35.12709] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Li R, Zheng J, Jiang M, Liu Y, Qin X, Wang X. Increased Digestive Proteases and Decreased β-Glucuronidase in Feces of Rats Treated with Sucralose and Saccharin—Another Critical Evidence That These Dietary Chemicals May Be Important Causative Factors for Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2016;22:E29-30. [DOI: 10.1097/mib.0000000000000859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
27 Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Boneh RS, Wine E, Damas OM, Syme G, Trakman GL, Yao CK, Stockhamer S, Hammami MB, Garces LC, Rogler G, Koutroubakis IE, Ananthakrishnan AN, McKeever L, Lewis JD. Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18:1381-1392. [PMID: 32068150 DOI: 10.1016/j.cgh.2020.01.046] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 47.0] [Reference Citation Analysis]
28 Parisio C, Lucarini E, Micheli L, Toti A, Di Cesare Mannelli L, Antonini G, Panizzi E, Maidecchi A, Giovagnoni E, Lucci J, Ghelardini C. Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin. Nutrients 2019;12:E22. [PMID: 31861862 DOI: 10.3390/nu12010022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
29 Celikbilek M, Dogan S, Ozbakır O, Zararsız G, Kücük H, Gürsoy S, Yurci A, Güven K, Yücesoy M. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 2013;27:72-6. [PMID: 23292894 DOI: 10.1002/jcla.21564] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 14.1] [Reference Citation Analysis]
30 Qin X. Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). Inflamm Bowel Dis 2017;23:E11-2. [PMID: 28079624 DOI: 10.1097/MIB.0000000000001010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Marques JG, Shokry E, Frivolt K, Werkstetter KJ, Brückner A, Schwerd T, Koletzko S, Koletzko B. Metabolomic Signatures in Pediatric Crohn's Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study. SLAS Technol 2021;26:165-77. [PMID: 33207993 DOI: 10.1177/2472630320969147] [Reference Citation Analysis]
32 Qin X. Does the association with NOD2, autophagy and some pathogens really mean Crohn's disease is caused by uncontrolled infection? Journal of Crohn's and Colitis 2014;8:87. [DOI: 10.1016/j.crohns.2013.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
34 de Bruyn M, Arijs I, Wollants W, Machiels K, Van Steen K, Van Assche G, Ferrante M, Rutgeerts P, Vermeire S, Opdenakker G. Neutrophil Gelatinase B–associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis: . Inflammatory Bowel Diseases 2014;20:1198-207. [DOI: 10.1097/mib.0000000000000068] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
35 Kriaa A, Jablaoui A, Mkaouar H, Akermi N, Maguin E, Rhimi M. Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation. FASEB J 2020;34:7270-82. [PMID: 32307770 DOI: 10.1096/fj.202000031RR] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
36 Rogler G, Scharl M, Spalinger M, Yilmaz B, Zaugg M, Hersberger M, Schreiner P, Biedermann L, Herfarth H. Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies? Mol Nutr Food Res 2021;65:e2000514. [PMID: 33433954 DOI: 10.1002/mnfr.202000514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 张云云, 王志荣. 心理因素在溃疡性结肠炎中的作用及机制. 世界华人消化杂志 2013; 21(19): 1823-1827 [DOI: 10.11569/wcjd.v21.i19.1823] [Reference Citation Analysis]
38 Griffiths OR, Landon J, Coxon RE, Morris K, James P, Adams R. Inflammatory bowel disease and targeted oral anti-TNFα therapy. Adv Protein Chem Struct Biol 2020;119:157-98. [PMID: 31997768 DOI: 10.1016/bs.apcsb.2019.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Di Narzo AF, Brodmerkel C, Telesco SE, Argmann C, Peters LA, Li K, Kidd B, Dudley J, Cho J, Schadt EE, Kasarskis A, Dobrin R, Hao K. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease. J Crohns Colitis 2019;13:462-71. [PMID: 30445421 DOI: 10.1093/ecco-jcc/jjy190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Legerská B, Chmelová D, Ondrejovič M. TLC-Bioautography as a fast and cheap screening method for the detection of α-chymotrypsin inhibitors in crude plant extracts. Journal of Biotechnology 2020;313:11-7. [DOI: 10.1016/j.jbiotec.2020.02.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
41 Qin X. Increased Milk Consumption but Decreased Risk of Crohnʼs Disease (CD): Critical Evidence Negated Causative Role of Mycobacterium avium Subspecies paratuberculosis (MAP) in CD. Inflammatory Bowel Diseases 2016;22:E37-8. [DOI: 10.1097/mib.0000000000000892] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Zhou K, Jiang M, Qin X, Wang X. Role of bilirubin in digestive proteases inactivation in the lower intestine. Dig Liver Dis. 2015;47:438-439. [PMID: 25732433 DOI: 10.1016/j.dld.2015.01.158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
43 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: A review. World J Gastroenterol 2015; 21(4): 1081-1090 [PMID: 25632180 DOI: 10.3748/wjg.v21.i4.1081] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
45 Konsavage WM Jr, Roper JN, Ishmael FT, Yochum GS. The Myc 3' Wnt responsive element regulates neutrophil recruitment after acute colonic injury in mice. Dig Dis Sci 2013;58:2858-67. [PMID: 23640071 DOI: 10.1007/s10620-013-2686-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
46 Follin-arbelet B, Moum B. Fluoride: a risk factor for inflammatory bowel disease? Scandinavian Journal of Gastroenterology 2016;51:1019-24. [DOI: 10.1080/00365521.2016.1177855] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
47 Qin X. Why is damage limited to the mucosa in ulcerative colitis but transmural in Crohn’s disease? World J Gastrointest Pathophysiol 2013; 4(3): 63-64 [PMID: 23946890 DOI: 10.4291/wjgp.v4.i3.63] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Qin X. How Sugar and Soft Drinks Are Related to Inflammatory Bowel Disease?: . Inflammatory Bowel Diseases 2016;22:E18-9. [DOI: 10.1097/mib.0000000000000774] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Han MK, Anderson R, Viennois E, Merlin D. Examination of food consumption in United States adults and the prevalence of inflammatory bowel disease using National Health Interview Survey 2015. PLoS One 2020;15:e0232157. [PMID: 32324818 DOI: 10.1371/journal.pone.0232157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ozaka S, Sonoda A, Ariki S, Kamiyama N, Hidano S, Sachi N, Ito K, Kudo Y, Minata M, Saechue B, Dewayani A, Chalalai T, Soga Y, Takahashi Y, Fukuda C, Mizukami K, Okumura R, Kayama H, Murakami K, Takeda K, Kobayashi T. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier. Genes Cells 2021. [PMID: 34379860 DOI: 10.1111/gtc.12888] [Reference Citation Analysis]
51 Shimshoni E, Yablecovitch D, Baram L, Dotan I, Sagi I. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 2015;64:367-72. [PMID: 25416065 DOI: 10.1136/gutjnl-2014-308048] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 8.7] [Reference Citation Analysis]
52 Li X, Liu Y, Wang Y, Li X, Liu X, Guo M, Tan Y, Qin X, Wang X, Jiang M. Sucralose Promotes Colitis-Associated Colorectal Cancer Risk in a Murine Model Along With Changes in Microbiota. Front Oncol 2020;10:710. [PMID: 32582527 DOI: 10.3389/fonc.2020.00710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
53 Parente JML, Coy CSR, Campelo V, Parente MPPD, Costa LA, Silva RMD, Stephan C, Zeitune JMR. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol 2015; 21(4): 1197-1206 [PMID: 25632193 DOI: 10.3748/wjg.v21.i4.1197] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
54 Qin X. Can inflammatory bowel disease really be solved by the multiple -omics and meta-omics analyses? Immunology Letters 2015;165:107-8. [DOI: 10.1016/j.imlet.2015.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Schiffman SS, Rother KI. Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Health B Crit Rev 2013;16:399-451. [PMID: 24219506 DOI: 10.1080/10937404.2013.842523] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 9.0] [Reference Citation Analysis]